2 months on 1mg Fin, 5% Min. Nizoral and derma stamp 1x a week
    Progress Pictures 10/11/2024

    From the encyclopedia
    Finasteride →

    Popular 5-alpha reductase inhibitor that lowers DHT, taken as a pill or used topically

    Minoxidil →

    Vasodilator used on the scalp and, at low doses, as a tablet

    Ketoconazole →

    Antifungal, best known as a dandruff shampoo

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    💊 Finasteride (oral) 1mg 1x daily 2 months
    💧 Minoxidil (topical) 5% 1x daily 2 months
    💧 Nizoral (topical) 1x weekly 2 months
    💧 derma stamp (topical) 1x weekly 2 months
    the tone is 😀 positive with good results.

    Other terms

    The user has been using 1mg finasteride, 5% minoxidil, Nizoral, and a derma stamp weekly for two months to treat hair loss. They are experiencing good results, with some skin flaking from microneedling.
    View this post in the Community →

    Similar Community Posts Join

    5 / 5 results

    Related Research

    6 / 6 results

      research Minoxidil: a comprehensive review

      16 citations , June 2021 in “Journal of Dermatological Treatment”
      This study reported that while topical minoxidil exhibits hair regrowth in androgenetic alopecia, oral minoxidil 5 mg/day was more effective than topical forms after six months, with low doses also potentially effective for women and other hair loss types.

      research Experimental and early investigational drugs for androgenetic alopecia

      11 citations , July 2017 in “Expert Opinion on Investigational Drugs”
      This review discusses current and emerging therapeutic strategies for androgenetic alopecia, noting limited evidence but suggesting areas such as prostaglandin analogs, PRP, and progenitor cell therapies as promising future directions.

      research Topical Antiandrogen Therapies for Androgenetic Alopecia and Acne Vulgaris

      7 citations , December 2019 in “American Journal of Clinical Dermatology”
      This review discusses the potential efficacy of topical antiandrogen therapies for treating androgenetic alopecia and acne vulgaris, finding promising results but highlighting the need for more comprehensive studies.